◆ 会议时间:2019年11月1-2日 ◆ 会议地点:美国 旧金山
◆ 会议简介:
2019 CSI 旧金山:先天性、结构性和瓣膜性心脏病、心房颤动、卒中预防和心力衰竭导管介入治疗大会(CSI San Francisco 2019)将于2019年11月1-2日在美国旧金山举行。今年的会议CSI将再次与加州大学旧金山分校(UCSF)合作,除了介绍心房颤动和心力衰竭的新疗法外,还将提供一个全面阐述结构性和瓣膜性心脏病导管和装置治疗为主要主题的会议。此外,还将开设成人先天性心脏病导管治疗课程。本次会议是专为介入心脏病专家、心胸外科医生、影像专家、麻醉师、护士、技术人员以及其他相关领域的医疗专业人士而设计 。
CSI基金会是一个非营利组织,重点聚焦先天性、结构性和瓣膜性心脏病介入治疗领域的最新研究进展,旨在通过为医生、技术人员和护士提供培训项目和教育机会,支持和促进全球的多学科协作,推进世界范围内结构性、瓣膜性和先天性心脏病的研究治疗。CSI每年除举办年度大会外,还在亚太、北美等地区举办区域性会议。
CSI will again join forces with the University of California, San Francisco to provide a meeting that will give attendees a comprehensive overview of major topics in catheter and device therapy for structural and valvular heart disease, in addition to novel therapies for atrial fibrillation and heart failure. There will also be sessions on catheter therapy for congenital heart disease in adults and innovation. The program will include lectures from leading experts in the field, case presentations with panel discussions, live and recorded cases, a review of ongoing and future studies and training sessions. The congress is designed for interventional cardiologists, cardiothoracic surgeons, anesthesiologists, EP specialists, imaging specialists, nurses, technicians and any other medical specialty involved in these procedures. With a focus on innovation we will also welcome device companies, engineers, start-ups and venture capitalists. ABSTRACT AND CASE SUBMISSION Submission deadline: July 26, 2019 Confirmation of acceptance: August 16, 2019
注册费: Online Registration is possible until October 29, 2019.TICKET | EARLY BIRD*** | NORMAL | ON-SITE | ONE DAY TICKET | ONE DAY TICKET ON-SITE | Physicians | $ 300 | $ 500 | $ 600 | $ 250 | $ 300 | Industry | - | $ 950 | $ 950 | $ 425 | $ 425 | Fellow* | $ 150 | $ 200 | $ 300 | $ 100 | $ 150 | Nurse, technician and associations* | $ 150 | $ 200 | $ 300 | $ 100 | $ 150 | Abstract & case presenter** | - | $ 250 | - | - | - |
* Only possible with confirmation of institution ** Subject to acceptance of case/abstract *** Early bird discount available until May 31, 2019
◆ 参会对象: 政府代表、医院管理者、科室主任、副主任、医生及从相关领域研究的专家、科研人员、医药企业等。
|